Endoscopic Retrograde Cholangiopancreatography, Endoscopic Ultrasound and Interventional Endoscopy in Pancreatico-biliary, Gastrointestinal and Esophageal Disorders
18 Years
N/A
Both
Ampullary Cancer, Duodenal Cancer, Bile Duct Cancer, Bile Duct Disorders, Gallstones, Obstructive Jaundice, Pancreatic Disorders (Noncancerous), Colorectal Cancer, Esophageal Cancer, Barrett's Esophagus, Gastric Malignancies, Pancreatic Cancer, Pediatric Gastroenterology, Cholangiocarcinoma, Pancreatic Pseudocysts, Acute and Chronic Pancreatitis, Recurrent Pancreatitis, Cholangitis, Bile Leak, Biliary Strictures, Pancreatic Divisum, Biliary and Pancreatic Stones, Choledocholithiasis
Trial Information
Endoscopic Retrograde Cholangiopancreatography, Endoscopic Ultrasound and Interventional Endoscopy in Pancreatico-biliary, Gastrointestinal and Esophageal Disorders
Our institution performs therapeutic ERCP (Endoscopic retrograde cholangiopancreatography ),
Endoscopic Ultrasound (EUS) and Interventional Endoscopy in around 1000 patients a year.
Procedures such as biliary and/or pancreatic sphincterotomy, stents placement (metallic or
plastic) and removal for revision, cysts and pseudocysts drainage are conducted in patients
suffering from pancreatico-biliary disorders, gastrointestinal disorders and esophageal
disorders. The investigators would like to assess prospectively the efficacy and safety of
these routine procedures to permit identification of technical details about the procedures
or other factors which might be associated with outcome or results. Assessment of these
details would help us with problem identification and recommendations to improve health
outcomes and quality of life in these patients.
Inclusion Criteria:
- Any subject that underwent Interventional Endoscopy for Pancreatico-biliary,
Gastrointestinal or Esophageal disorders.
- Above the age of 18 years
Exclusion Criteria:
- Any group that did not undergo Interventional Endoscopy for Pancreatico-biliary,
Gastrointestinal or Esophageal disorders.
- Below the age of 18 years
Type of Study:
Observational
Study Design:
Time Perspective: Prospective
Outcome Measure:
Establishing a database that contains all Interventional Endoscopies
Outcome Description:
Collection of procedure specific details of all Interventional Endoscopies
Outcome Time Frame:
5 years
Safety Issue:
Yes
Principal Investigator
Michel Kahaleh, MD
Investigator Role:
Principal Investigator
Investigator Affiliation:
Weill Medical College of Cornell University
Authority:
United States:Weill Medical College of Cornell University IRB
Study ID:
1104011642
NCT ID:
NCT01438385
Start Date:
July 2011
Completion Date:
July 2016
Related Keywords:
- Ampullary Cancer
- Duodenal Cancer
- Bile Duct Cancer
- Bile Duct Disorders
- Gallstones
- Obstructive Jaundice
- Pancreatic Disorders (Noncancerous)
- Colorectal Cancer
- Esophageal Cancer
- Barrett's Esophagus
- Gastric Malignancies
- Pancreatic Cancer
- Pediatric Gastroenterology
- Cholangiocarcinoma
- Pancreatic Pseudocysts
- Acute and Chronic Pancreatitis
- Recurrent Pancreatitis
- Cholangitis
- Bile Leak
- Biliary Strictures
- Pancreatic Divisum
- Biliary and Pancreatic Stones
- Choledocholithiasis
- Pancreatico-biliary
- Biliary
- Bile Duct
- Gastrointestinal disorder
- Esophageal disorder
- Barrett Esophagus
- Bile Duct Diseases
- Neoplasms
- Cholangitis
- Gallstones
- Cholelithiasis
- Cholecystolithiasis
- Colorectal Neoplasms
- Duodenal Neoplasms
- Esophageal Diseases
- Esophageal Neoplasms
- Jaundice
- Jaundice, Obstructive
- Stomach Neoplasms
- Pancreatic Diseases
- Pancreatic Neoplasms
- Pancreatic Pseudocyst
- Pancreatitis
- Pancreatitis, Chronic
- Cholangiocarcinoma
- Cholestasis
- Choledocholithiasis
- Bile Duct Neoplasms
- Constriction, Pathologic
Name | Location |
|---|---|
| Weill Cornell Medical College of Cornell University | New York, New York 10021 |
